Hsinchu, Taiwan

Er-Yuan Chung


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Er-Yuan Chung: Innovator in Pharmaceutical Nanoparticles

Introduction

Er-Yuan Chung is a distinguished inventor based in Hsinchu, Taiwan, renowned for his contributions to the field of pharmaceuticals. With a focus on innovative drug delivery systems, he holds a patent that significantly advances the methodology for administering medications.

Latest Patents

Chung's sole patent revolves around a novel pharmaceutical composition of nanoparticles. This innovative invention discloses a composition that includes positively charged chitosan nanoparticles combined with a negatively charged substrate, optionally accompanied by a zero-charge compound or a tumor necrosis factor inhibitor for enhanced oral delivery. The unique characteristics of these chitosan-based nanoparticles allow for an effective positive surface charge, which markedly improves the permeability of drugs given orally, presenting an exciting area of research in the medical field.

Career Highlights

Throughout his career, Er-Yuan Chung has worked with notable organizations, including GP Medical, Inc. and National Tsing Hua University. His positions at these institutions have provided him with robust platforms to develop and validate his innovative ideas, contributing to the advancement of pharmaceutical technologies.

Collaborations

Er-Yuan Chung has collaborated with talented individuals such as Hsing-Wen Sung and Ha Giang Thi Nguyen, further enriching his experience and expanding the scope of his research. These collaborations not only enhance the research environment but also foster innovative solutions to complex medical challenges.

Conclusion

In summary, Er-Yuan Chung's inventive spirit and commitment to advancing pharmaceutical sciences through his patented nanoparticle composition highlight his significant contributions to medicine. His collaborations and experience with reputable organizations underscore his position as a key figure in the field of drug delivery innovations, with potential implications for improving patient care worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…